Consequences Of Cannabinoid And Monoaminergic System Disruption In A Mouse Model Of Autism Spectrum Disorders

Autism Schizophrenia

Key Findings

Thus our data provides a basis for further studies in evaluating the role of the cannabinoid and monoaminergic systems in the etiology of ASDs and whether the BTBR mice can model both schizophrenia and ASDs. The researchers note: "It is tempting to suggest the evaluation of Δ9-THC or other cannabinoids with reduced psychoactivity in irritability, tantrums and self-injurious behavior associated with autistic individuals."

Information and Links


Link: Consequences Of Cannabinoid And Monoaminergic System Disruption In A Mouse Model Of Autism Spectrum Disorders

Year: 2011

DOI: 10.2174/157015911795017047


Ratings

(How Ratings Work)

Autism — 2


Possible to probable range of efficacy of cannabis for treatment of Autism according to the results found in this study.

Schizophrenia — 2


Possible to probable range of efficacy of cannabis for treatment of Schizophrenia according to the results found in this study.

Drugs Used

Delta-9-THC

MDMA

Methamphetamine

MPTP